SPY423.59-0.72 -0.17%
DIA343.08-2.04 -0.59%
IXIC14,131.27+61.85 0.44%

Novavax Q1 EPS $(3.05) Beats $(3.60) Estimate, Sales $447.23M Beat $233.90M Estimate

Novavax (NASDAQ:NVAX) reported quarterly losses of $(3.05) per share which beat the analyst consensus estimate of $(3.60) by 15.28 percent. This is a 425.86 percent decrease over losses of $(0.58) per share from the same

05/10/2021 16:03
Novavax (NASDAQ:NVAX) reported quarterly losses of $(3.05) per share which beat the analyst consensus estimate of $(3.60) by 15.28 percent. This is a 425.86 percent decrease over losses of $(0.58) per share from the same period last year. The company reported quarterly sales of $447.23 million which beat the analyst consensus estimate of $233.90 million by 91.21 percent. This is a 13.14K percent increase over sales of $3.38 million the same period last year.